Indapamide Ratiopharm

Quick links

Choose a section

Quick links to important sections

Advertisements

Indapamide Ratiopharm

Advertisements
Advertisements

Treatment option: Hypertension

Advertisements

Overview of Indapamide Ratiopharm

As a foundational overview, this section identifies the nature, classification, and general therapeutic purpose of Indapamide Ratiopharm, strictly excluding details on dosage, specific indications, administration, or safety.


Property Description
Active Ingredient Indapamide
Form Film-coated tablet (oral)
Pharmacological Class Thiazide-like Diuretic, Antihypertensive Agent
Common Use Managing high blood pressure
Origin Synthetic, Sulfonylurea derivative

What Type of Medicine is Indapamide and How Does It Work Generally?

Indapamide Ratiopharm is a prescription-only medicine from the manufacturer Ratiopharm, distinguished by its brand focus on quality within the generic market. Its active substance, Indapamide, is classified as a thiazide-like diuretic and a primary antihypertensive agent. This means the drug is fundamentally used to manage elevated blood pressure, or hypertension. The action of Indapamide is considered dual: it functions as a saluretic, promoting the removal of excess sodium and water from the body through the kidneys, and simultaneously causes peripheral vasodilation, a relaxation and widening of the small blood vessels. Indapamide is used as a treatment option for essential hypertension. This mechanism supports its role in sustained blood pressure control.

Composition, Origin, and Pharmaceutical Form

The medicine is composed of the synthetic active ingredient Indapamide, which is chemically defined as a sulfonylurea derivative. It is administered through the oral route in the form of a film-coated tablet. The Ratiopharm brand typically presents this medication as a single-substance product, containing Indapamide as the sole therapeutic agent. Oral Indapamide products are available in formulations offering both immediate-release (IR) and prolonged-release (PR) of the active component. This ensures patients can receive the formulation that best maintains consistent blood pressure regulation.

What is the General Therapeutic Purpose of Indapamide?

The overarching therapeutic purpose of Indapamide is to lower and maintain control over high blood pressure, a common cardiovascular management scenario. By effectively decreasing the volume of circulating fluid and easing the resistance in the blood vessels, the medicine directly reduces the strain and workload placed upon the heart and arterial walls. The general benefit is the sustained normalization of blood pressure, a critical measure in reducing long-term cardiovascular risk, a conclusion supported by clinical consensus.

Regulatory References

  1. National Institute for Health and Care Excellence (NICE)
Advertisements

What side effects are possible with Indapamide Ratiopharm?

Possible side effects and safety information

The official safety documentation for Indapamide, a thiazide-like diuretic, outlines adverse reactions categorized by their frequency and the body system affected. The most commonly documented risk is related to metabolism and nutrition disorders, primarily Hypokalemia (low blood potassium), which is classified as common in regulatory sources.

Other adverse reactions are grouped into standard System-Organ Classes (SOCs), including effects on the nervous system ( Headache, Dizziness) and the gastrointestinal system ( Nausea, Constipation). These common and rare reactions establish the baseline risk profile for the medicine.


Serious and Rare Adverse Reactions

Official labels describe very rare but clinically significant adverse reactions. These include severe dermatological events such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), as well as Angioedema (swelling). Effects on the cardiovascular system can include specific arrhythmias like Torsades de pointes, a risk that may be increased by Hypokalemia.

Safety Considerations and Restrictions

Safety documents specify constraints for use. Indapamide is contraindicated in individuals with severe pre-existing conditions, including severe renal failure ( Anuria), severe hepatic impairment, or Hypokalemia. This restriction defines populations where the documented risks are considered unacceptable.

Furthermore, official safety notes indicate that certain adverse effects, such as Fatigue and Dizziness, are more likely to occur at the initiation of treatment or after a dose increase. Photosensitivity reactions are a documented dermatological risk associated with exposure.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Indapamide primarily manifests as an exaggerated physiological effect, resulting in severe volume depletion and critical electrolyte disturbances, particularly hypokalaemia (low potassium) and hyponatraemia (low sodium). Clinical signs documented in official labeling include pronounced hypotension (low blood pressure), dizziness, mental confusion, nausea, and vomiting. Severe fluid loss may progress from excessive urination to oliguria or anuria (absence of urine production).

Due to the risks associated with these imbalances, immediate medical attention must be sought if an overdose is suspected. The most critical risks documented in regulatory sources are severe ventricular arrhythmias, such as Torsade de Pointes, which are linked to severe hypokalaemia. Additionally, in patients with hepatic impairment, the electrolyte shifts may precipitate Hepatic Encephalopathy.

Official documents confirm that no specific antidote is known for Indapamide overdose. Management is supportive and symptomatic, focusing on the mandatory restoration of fluid and electrolyte balance to correct physiological deficits. Procedures like gastric lavage or the use of activated charcoal may be considered to eliminate the drug.

Advertisements

Therapeutic Uses of Indapamide Ratiopharm

Indapamide Ratiopharm is commonly used to help with the long-term management of essential hypertension, a condition characterized by consistently elevated systolic and diastolic blood pressure. The primary therapeutic benefit may assist with maintaining target blood pressure levels. This supports the overall effort to lower the systemic burden, which contributes to easing the risk associated with challenging cardiovascular manifestations, such as stroke.

The medication is relevant in contexts marked by increased discomfort or tension where patients may experience symptoms related to systemic imbalance, which often results in peripheral swelling or edema. Indapamide Ratiopharm plays a role in managing systemic imbalance related to fluid volume. This assists with easing the symptoms of physical discomfort associated with fluid retention. The medicine is commonly used to help with managing high blood pressure and is relevant for easing swelling linked to certain cardiovascular conditions.

“This medication supports the overall effort to ease the symptom load associated with persistent pressure elevation.”

Quick Fact: Relief for Swelling
Indapamide supports patients during episodes of heightened discomfort by assisting with fluid volume management.

Regulatory References

  1. NIH MedlinePlus Drug Information
Advertisements

Eligibility and Restrictions for Use

The eligibility profile for Indapamide Ratiopharm is defined by authoritative government regulatory criteria, separating absolute prohibitions from conditional use.

Eligibility Status Applicable Population/Condition
Contraindicated Patients with known hypersensitivity to indapamide or other sulfonamides must not use this medicine. It is also prohibited for those with severe renal failure (such as anuria) or severe hepatic impairment, including hepatic encephalopathy. Individuals experiencing refractory hypokalaemia (low potassium) are also excluded.
Not Recommended Use is not recommended for children and adolescents (under 18) due to a lack of established safety and efficacy data. The medicine should be avoided during pregnancy and is not recommended for breastfeeding mothers.
Conditional Use Older adults may be treated only if their renal function is normal or minimally impaired. Caution is required for patients with pre-existing conditions like gout or hyperuricemia, Systemic Lupus Erythematosus (SLE), or diabetes.

These official rules establish who can use the medicine (generally adults) and define all absolute and conditional eligibility constraints based solely on the official regulatory documentation.

Advertisements

What should I know about interactions with other medicines?

Indapamide Ratiopharm's official interaction profile is primarily structured around the risk of electrolyte imbalance, which governs the co-administration constraints for various medicinal products as stated in regulatory documents.


Interaction Scope

Category Official Regulatory Statement
Contraindicated Combinations Co-administration with Aliskiren is contraindicated in diabetic patients with renal impairment. Sultopride and other specific non-antiarrhythmic Torsades de pointes (TdP)-inducing agents are prohibited combinations.
Exposure-Modifying Substances Indapamide causes a reduction in the renal clearance of Lithium salts, leading to increased plasma levels and documented toxicity risk.
Pharmacodynamic Risk Concomitant use with other Potassium-depleting agents (e.g., systemic corticosteroids, stimulant laxatives) creates an additive risk of hypokalaemia. This potassium reduction also magnifies the risk of digitalis toxicity and severe ventricular arrhythmias with TdP-risk medicines.
Efficacy Alterations Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), including high-dose acetylsalicylic acid (ge 3 g/day), are documented to potentially cause a reduction of the antihypertensive effect and risk of acute kidney injury in dehydrated patients.
Timing Requirements Initiation of ACE Inhibitors may require discontinuation of Indapamide three days prior in sodium-depleted patients to mitigate the regulatory-documented risk of sudden hypotension and acute renal failure.

Population-Specific Interaction Notes

The interaction profile states that patients with severe hepatic impairment or progressive liver disease require special caution, as minor alterations in fluid or electrolyte balance caused by interactions may precipitate hepatic coma.

Advertisements

Mechanism of Action

Targeting Salt Transport in the Kidney

This primary mechanism involves the inhibition of the sodium-chloride cotransporter ( NCC) in the kidney's distal convoluted tubule. By blocking this specific molecular target, Indapamide prevents the reabsorption of salt and water, which leads to a decrease in plasma volume.

Direct Action on Vascular Smooth Muscle

The second, non-diuretic mechanism involves the modulation of ion handling, particularly Ca^2+, within the walls of small arteries. This action causes the smooth muscle cells to relax, leading to vasodilation and a reduction in the overall resistance against the heart's ejection force.

Mechanism Limitations and Effect Dynamics

The diuretic response depends heavily on adequate kidney filtration to deliver salt to the target site ( NCC), limiting the natriuretic response in cases of poor renal function. Furthermore, the full physiological effect is gradual, as volume decrease occurs first, while the maximal reduction in Peripheral Vascular Resistance (PVR) develops over a period of several weeks.

Advertisements

Dosage and Administration Information

Indapamide Ratiopharm is administered through the oral route in the form of a film-coated tablet. The primary usage pattern for managing hypertension involves taking a single dose once daily, preferably in the morning, which helps establish a consistent twenty-four-hour rhythm. Tablets are generally available in strengths such as 1.25 mg and 2.5 mg, with 1.5 mg often available for the prolonged-release (PR) formulation.

The established dosing regimens vary by region, though they follow a similar once-daily pattern. In many European regions, the standard daily dose for essential hypertension is 2.5 mg. In other regions, prescribing information may specify a starting dose of 1.25 mg once daily. Dose adjustment, if necessary, is typically performed at intervals of four weeks to evaluate the full therapeutic effect. The tablet may be taken with or without food; however, it must be swallowed whole with water and should not be crushed or chewed to preserve the intended release profile of the active substance.

Specific restrictions exist regarding the use of Indapamide based on patient population. Use in the pediatric population (children and adolescents) is not recommended because the safety and efficacy profiles have not been established. Furthermore, official administration protocols require the medicine to be withheld when a patient has severe impairment of either renal function or hepatic function, as the drug’s profile makes its use unsuitable in these severe clinical states. The general principle is long-term use for chronic management, with the full blood pressure reduction effect often requiring several months to manifest.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies for Indapamide Ratiopharm


Evidence for Managing Essential High Blood Pressure

Researchers have conducted numerous Randomized Controlled Trials (RCTs) and supporting meta-analyses to explore the use of Indapamide in adults with essential hypertension. The core evidence consists of studies where researchers explored how blood pressure changes over defined time intervals. Outcomes monitored included the changes measured in systolic and diastolic blood pressure.

Research also explored changes in Left Ventricular Hypertrophy (LVH) size and mass, which is a functional imbalance marker. The findings describe patterns observed in the studied populations related to exploring blood pressure targets and maintenance. However, the majority of these initial efficacy trials had follow-up durations that were limited to short-term periods, such as 8 to 12 weeks. This means that while research provides insight into short-term changes in blood pressure, the direct correlation between these early measurements and very long-term outcomes is not fully established by these specific trials.


Evidence for Major Cardiovascular and Cerebrovascular Risk

To characterize the research base for major clinical outcomes, studies have been conducted using large-scale, long-term Randomized Controlled Trials (RCTs). These studies were applied in research contexts involving high-risk adults and monitored outcomes related to systemic or functional imbalance over several years. Outcomes measured focused on composite endpoints, which include major vascular events and metrics related to overall and cardiovascular death.

Research examined Indapamide in cohorts of individuals who have already experienced a prior stroke, exploring outcomes relevant in evidence describing how symptoms are measured in a secondary prevention setting. The foundational research data for major cardiovascular outcomes was observed in studies where the medicine was used as part of a combination treatment with another drug. This structural characteristic means that data specifically addressing Indapamide as a single agent (monotherapy) for long-term outcomes are not widely available in the key outcome studies.


What Research is Still Unclear or Under Investigation

Evidence highlights what is known and what is still uncertain about the research structure. Comprehensive comparative evidence against all available antihypertensive drug classes for all populations and outcomes is not yet complete. The existing studies provide limited insight into areas like the long-term outcomes of monotherapy, and research is ongoing to continually build out the evidence landscape.

Key Studies & References

  1. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial
  2. Thiazide-like diuretics versus thiazide diuretics for hypertension: A systematic review and meta-analysis
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Indapamide Ratiopharm (FAQ)


Q: Is Indapamide Ratiopharm the same as Indapamide?

Indapamide Ratiopharm is the specific name of the medicine made by the manufacturer Ratiopharm. The active substance within the tablet is called Indapamide, which is the generic name for the drug. Indapamide is available from various pharmaceutical companies under different brand names.


Q: What is the 'Ratiopharm' part of the name for?

The 'Ratiopharm' part of the name identifies the manufacturer or marketing authorization holder responsible for producing and supplying this specific version of the medicine. This is common practice for medicines that use a generic active ingredient.


Q: How long do the effects of Indapamide Ratiopharm last?

Official information supports the medicine being taken once daily to maintain a consistent therapeutic effect for the full day. The elimination half-life is described as approximately 15 to 18 hours, which is consistent with the recommendation for single daily administration.


Q: What happens if I miss a dose of Indapamide Ratiopharm?

Regulatory patient information suggests taking the missed dose as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped entirely. This approach is intended to prevent the potential risk associated with doubling the dose.


Q: Can Indapamide Ratiopharm cause dehydration?

Because the medicine increases the elimination of water and salt from the body, official regulatory documentation mentions a potential risk of dehydration. For example, official reports of overdose also list dehydration as a possible consequence.


Q: What foods should be limited when on Indapamide Ratiopharm?

Official documentation does not typically specify general food restrictions. However, regulatory warnings focus on the medicine's potential to cause low potassium levels ( Hypokalaemia), a key consideration that may be monitored in relation to nutrition.


Q: Can I drink alcohol while using Indapamide Ratiopharm?

Official information indicates that alcohol consumption may have an additive effect in lowering blood pressure. This may potentially lead to a higher chance of experiencing symptoms such as lightheadedness or dizziness.


Q: Can Indapamide Ratiopharm be taken with other blood pressure medications?

Yes, official regulatory documents state that Indapamide is indicated for the treatment of high blood pressure alone or in combination with other antihypertensive drugs. Combination use is supported by regulatory documents and may involve medical monitoring.


Q: Is Indapamide Ratiopharm a beta-blocker?

No, Indapamide is not classified as a beta-blocker. Official sources classify this medicine as a thiazide-like diuretic and an antihypertensive agent, meaning it works through a different mechanism.


Q: Can Indapamide Ratiopharm be taken at night?

The official recommendation is generally to take the medicine in the morning. This timing is suggested because the drug increases the need to urinate, which is suggested to minimize the potential for increased nighttime urination.


Q: Is Indapamide Ratiopharm a common drug choice for hypertension?

Official guidelines and reviews place Indapamide within the list of established treatment options for adults with essential high blood pressure. This indicates its established and recognized role in the management of high blood pressure.


Q: What if I feel dizzy after starting Indapamide Ratiopharm?

Regulatory documents state that when side effects such as dizziness or fatigue occur, caution is advised. Official information suggests avoiding activities like driving or operating machinery until the patient knows how the medicine affects them.


Q: Does Indapamide Ratiopharm affect cholesterol levels?

Regulatory documents state that Indapamide does not appear to alter lipid metabolism. This includes levels of triglycerides, LDL-cholesterol, and HDL-cholesterol.


Q: How does Indapamide Ratiopharm work differently than other water pills?

Official descriptions state that its action is considered dual. It involves both a diuretic effect (helping the kidneys remove salt and water) and an extra-renal mechanism that acts directly to relax and widen blood vessels (vasodilation).


Q: Can I drive or operate machinery while taking Indapamide Ratiopharm?

Regulatory documents mention the potential for side effects like dizziness or fatigue, particularly at the beginning of treatment or following a dose increase. Official information suggests that caution is appropriate regarding activities such as driving or operating machinery.


Q: Is it possible to be allergic to Indapamide Ratiopharm?

Yes, official regulatory documents list a known hypersensitivity to the active substance (Indapamide) or to other sulfonamides as a reason the medicine must not be used (a contraindication).


Q: What ingredients are in Indapamide Ratiopharm besides the active substance?

The medicine contains the active substance, Indapamide, along with other inactive ingredients, known as excipients. The official product documentation (SmPC) lists these excipients, which may commonly include substances like lactose monohydrate.


Q: Can Indapamide Ratiopharm affect my blood sugar?

Regulatory documents state that monitoring of blood glucose may be necessary for patients with pre-existing diabetes. This reflects the potential for the medicine to impact blood sugar levels, especially when electrolyte imbalances occur.


Q: Is Indapamide Ratiopharm commonly used on its own or with other drugs?

The medicine is officially indicated for the treatment of high blood pressure both alone (monotherapy) or in combination with other prescribed medicines. Research evidence also supports its use as part of combination treatments.


Q: How often are people typically monitored by a doctor while on this medicine?

Official documents describe that the monitoring of electrolyte levels (such as plasma sodium and potassium) and kidney function is often necessary. This is especially true at the start of treatment and in specific patient groups.


Q: Is Indapamide Ratiopharm a generic medicine?

Indapamide is the internationally recognized generic name for the active ingredient. The 'Ratiopharm' brand is associated with marketing this generic active ingredient.


Q: Can Indapamide Ratiopharm be crushed or split?

Official instructions state that the tablets must be swallowed whole with water. They should not be crushed, split, or chewed in order to preserve the intended release profile of the active substance.


Q: Is it common for doctors to change the dose over time?

Official dosing guidelines describe that any dose adjustment, if required, is typically performed at intervals of several weeks (such as four weeks). This interval is required to fully evaluate the effects of the medicine before a change is made.


Q: Can Indapamide Ratiopharm be taken on an empty stomach?

Official instructions state that the tablet may be taken with or without food. This means the timing relative to meals does not generally alter the effectiveness of the medicine.


Q: Are there studies comparing Indapamide Ratiopharm to placebo?

Yes, the research evidence supporting the medicine's use includes findings from Randomized Controlled Trials (RCTs). In these studies, the drug's effects on blood pressure were compared to a baseline or sometimes to an inactive substance (placebo).

Advertisements

How should Indapamide Ratiopharm be stored and disposed of?

Storage Conditions for Indapamide Ratiopharm

Indapamide Ratiopharm tablets must be stored at a temperature not exceeding 25°C (77°F). It is mandatory to keep the medicine in its original container, which must be kept tightly closed, and stored away from excess heat, moisture, and freezing.

To ensure safety, the product must always be stored out of the sight and reach of children.


Disposal Instructions

Do not dispose of this medicine via wastewater or household waste. Any unused or expired Indapamide Ratiopharm should be handled as pharmaceutical waste and disposed of in accordance with local requirements for unused medicines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Indapamide Ratiopharm found in:

A-Z Index: